Cargando…
ARMS技术联合Taqman探针检测100例非小细胞肺癌EGFR基因突变
BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor (EGFR) gene mutation is the most important predictor of the efficiency of EGFR-tyrosine kinase inhibitors in the treatment of non-small cell lung cancer (NSCLC). The detection of EGFR gene mutations can guide individual therapies for NSCLC....
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000453/ https://www.ncbi.nlm.nih.gov/pubmed/23327870 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.01.05 |